Literature DB >> 14723614

Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study.

S L S Halder1, G R Locke, N J Talley, S L Fett, A R Zinsmeister, L J Melton.   

Abstract

BACKGROUND: The health-related quality of life is impaired in patients with functional gastrointestinal disorders seen in referral centres. AIM: To determine whether the health-related quality of life is impaired in subjects with functional disorders in the community and whether any differences can be explained by psychological co-morbidity.
METHODS: In a population-based, nested, case-control study, subjects reporting symptoms of either dyspepsia or irritable bowel syndrome and healthy controls were interviewed and completed a battery of psychological measures plus a validated, generic, health-related quality of life measure (Medical Outcomes Study 36-item short form health survey, SF-36). The association between irritable bowel syndrome and dyspepsia and the physical and mental composite scores of SF-36 were assessed with and without adjustment for psychological state.
RESULTS: One hundred and twelve cases (30 dyspepsia, 39 irritable bowel syndrome, 32 dyspepsia and irritable bowel syndrome and 11 gastrointestinal symptoms but not dyspepsia or irritable bowel syndrome) and 110 controls were enrolled. In the unadjusted linear regression models, irritable bowel syndrome (but not dyspepsia) was negatively associated with the physical composite score (P < 0.05); in an adjusted model, the association between the physical health-related quality of life and irritable bowel syndrome was explained by the Symptom Checklist-90 somatization score alone. In unadjusted models, irritable bowel syndrome and dyspepsia were each negatively associated with the mental composite score (P < 0.05). The association between the mental health-related quality of life and dyspepsia remained after adjusting for psychological covariates, but the association between this and irritable bowel syndrome was not significant after adjustment.
CONCLUSIONS: In the community, health-related quality of life is impaired in subjects with irritable bowel syndrome and dyspepsia; however, much of this association can be explained by psychological factors.

Entities:  

Mesh:

Year:  2004        PMID: 14723614     DOI: 10.1111/j.0269-2813.2004.01807.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  49 in total

1.  Clinical utility of wireless motility capsule in patients with suspected multiregional gastrointestinal dysmotility.

Authors:  Zubin Arora; Jose Mari Parungao; Rocio Lopez; Cynthia Heinlein; Janice Santisi; Sigurbjorn Birgisson
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

2.  What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome? Are current IBS symptom thresholds clinically meaningful?

Authors:  Natasha A Koloski; Philip M Boyce; Michael P Jones; Nicholas J Talley
Journal:  Qual Life Res       Date:  2011-08-11       Impact factor: 4.147

3.  Effects and possible mechanisms of acupuncture at ST36 on upper and lower abdominal symptoms induced by rectal distension in healthy volunteers.

Authors:  Jinsong Liu; Hong Huang; Xiaohong Xu; J D Z Chen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-05-16       Impact factor: 3.619

Review 4.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

5.  Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort study.

Authors:  M A McNally; G R Locke; A R Zinsmeister; C D Schleck; J Peterson; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2008-08-01       Impact factor: 8.171

6.  Racial differences in epidemiology of irritable bowel syndrome alone, un-investigated dyspepsia alone, and "overlap syndrome" among african americans compared to Caucasians: a population-based study.

Authors:  Anil Minocha; William Chad; Wigington Do; William D Johnson
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

Review 7.  Case-control studies in pharmacoeconomic research: an overview.

Authors:  J Jaime Caro; Krista F Huybrechts
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

8.  Validation of Self-administrated Questionnaire for Psychiatric Disorders in Patients with Functional Dyspepsia.

Authors:  Ada W Y Tse; Larry H Lai; C C Lee; Kelvin K F Tsoi; Vincent W S Wong; Yawen Chan; Joseph J Y Sung; Francis K L Chan; Justin C Y Wu
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

9.  Effect of electroacupuncture on visceral hyperalgesia, serotonin and fos expression in an animal model of irritable bowel syndrome.

Authors:  Justin Cy Wu; Eric Tc Ziea; Lixing Lao; Emma Fc Lam; Catherine Sm Chan; Angela Yq Liang; Sunny Lh Chu; David Tw Yew; Brian M Berman; Joseph Jy Sung
Journal:  J Neurogastroenterol Motil       Date:  2010-07-26       Impact factor: 4.924

10.  Upper gastrointestinal symptoms, psychosocial co-morbidity and health care seeking in general practice: population based case control study.

Authors:  Linda E Bröker; Gerard J B Hurenkamp; Gerben ter Riet; François G Schellevis; Hans G Grundmeijer; Henk C van Weert
Journal:  BMC Fam Pract       Date:  2009-09-09       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.